Greg Pyszczymuka - Net Worth and Insider Trading
Greg Pyszczymuka Net Worth
The estimated net worth of Greg Pyszczymuka is at least $27,400 dollars as of 2024-05-05. Greg Pyszczymuka is the Chief Commercial Officer of Aytu BioPharma Inc and owns about 9,103 shares of Aytu BioPharma Inc (AYTU) stock worth over $27,400. Details can be seen in Greg Pyszczymuka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Greg Pyszczymuka has not made any transactions after 2022-12-19 and currently still holds the listed stock(s).
Transaction Summary of Greg Pyszczymuka
Greg Pyszczymuka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greg Pyszczymuka owns 1 companies in total, including Aytu BioPharma Inc (AYTU) .
Click here to see the complete history of Greg Pyszczymuka’s form 4 insider trades.
Insider Ownership Summary of Greg Pyszczymuka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AYTU | Aytu BioPharma Inc | 2023-04-25 | Chief Commerical Officer |
Greg Pyszczymuka Latest Holdings Summary
Greg Pyszczymuka currently owns a total of 1 stock. Greg Pyszczymuka owns 9,103 shares of Aytu BioPharma Inc (AYTU) as of December 19, 2022, with a value of $27,400.
Latest Holdings of Greg Pyszczymuka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AYTU | Aytu BioPharma Inc | 2022-12-19 | 9,103 | 3.01 | 27,400 |
Holding Weightings of Greg Pyszczymuka
Greg Pyszczymuka Form 4 Trading Tracker
According to the SEC Form 4 filings, Greg Pyszczymuka has made a total of 1 transactions in Aytu BioPharma Inc (AYTU) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aytu BioPharma Inc is the acquisition of 5,000 shares on December 19, 2022, which cost Greg Pyszczymuka around $24,000.
Insider Trading History of Greg Pyszczymuka
- 1
Greg Pyszczymuka Trading Performance
GuruFocus tracks the stock performance after each of Greg Pyszczymuka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Greg Pyszczymuka is -51.97%. GuruFocus also compares Greg Pyszczymuka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Greg Pyszczymuka within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Greg Pyszczymuka's insider trading performs compared to the benchmark.
Performance of Greg Pyszczymuka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.95 | | | | | |
| Relative Return to S&P 500(%) | -22.08 | | | | | |
Greg Pyszczymuka Ownership Network
Greg Pyszczymuka Owned Company Details
What does Aytu BioPharma Inc do?
Who are the key executives at Aytu BioPharma Inc?
Greg Pyszczymuka is the Chief Commerical Officer of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Operating Officer Christopher Brooke , Chief Business Officer Jarrett Disbrow , and Chief Financial Officer Mark K Oki .
Aytu BioPharma Inc (AYTU) Insider Trades Summary
Over the past 18 months, Greg Pyszczymuka made 1 insider transaction in Aytu BioPharma Inc (AYTU) with a net purchase of 100,000. Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 348,371 shares made by Joshua R. Disbrow , a net purchase of 90,000 shares made by Mark K Oki ,
In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 40,219 shares were bought by its insiders, resulting in a net purchase of 40,219 shares.
Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aytu BioPharma Inc Insider Transactions
Greg Pyszczymuka Mailing Address
Above is the net worth, insider trading, and ownership report for Greg Pyszczymuka. You might contact Greg Pyszczymuka via mailing address: C/o Aytu Biopharma, Inc., 373 Inverness Parkway, Suite 206, Englewood Co 80112.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
